BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 37080502)

  • 1. The influence of overweight and obesity on participation in cervical cancer screening: A systematic review and meta-analysis.
    Sand FL; Urbute A; Ring LL; Kjaer AK; Belmonte F; Kjaer SK
    Prev Med; 2023 Jul; 172():107519. PubMed ID: 37080502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Body Mass Index With Adherence to Cervical Cancer Screening Recommendations in Hispanic Women.
    Pérez CM; González-Barrios D; Ramos-Cartagena JM; Ortiz AP
    J Low Genit Tract Dis; 2020 Jan; 24(1):14-20. PubMed ID: 31860570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast, Cervical, and Colorectal Cancer Screening Adherence: Effect of Low Body Mass Index in Women.
    Charkhchi P; Schabath MB; Carlos RC
    J Womens Health (Larchmt); 2020 Jul; 29(7):996-1006. PubMed ID: 31928405
    [No Abstract]   [Full Text] [Related]  

  • 4. Women with obesity participate less in cervical cancer screening and are more likely to have unsatisfactory smears: Results from a nationwide Danish cohort study.
    Urbute A; Kjaer SK; Kesmodel US; Frederiksen K; Thomsen LT
    Prev Med; 2022 Jun; 159():107072. PubMed ID: 35460722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiologic Evidence That Excess Body Weight Increases Risk of Cervical Cancer by Decreased Detection of Precancer.
    Clarke MA; Fetterman B; Cheung LC; Wentzensen N; Gage JC; Katki HA; Befano B; Demarco M; Schussler J; Kinney WK; Raine-Bennett TR; Lorey TS; Poitras NE; Castle PE; Schiffman M
    J Clin Oncol; 2018 Apr; 36(12):1184-1191. PubMed ID: 29356609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Body weight and cancer screening among women.
    Fontaine KR; Heo M; Allison DB
    J Womens Health Gend Based Med; 2001 Jun; 10(5):463-70. PubMed ID: 11445045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overweight and obesity as risk factors for cervical cancer and detection of precancers among screened women: A nationwide, population-based cohort study.
    Urbute A; Frederiksen K; Thomsen LT; Kesmodel US; Kjaer SK
    Gynecol Oncol; 2024 Feb; 181():20-27. PubMed ID: 38103421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Body mass index and cervical cancer screening among women aged 15-69 years in Eswatini: evidence from a population-based survey.
    Motsa MPS; Estinfort W; Phiri YVA; Simelane MS; Ntenda PAM
    BMC Public Health; 2023 Aug; 23(1):1638. PubMed ID: 37635230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Body mass index and participation in organized mammographic screening: a prospective cohort study.
    Hellmann SS; Njor SH; Lynge E; von Euler-Chelpin M; Olsen A; Tjønneland A; Vejborg I; Andersen ZJ
    BMC Cancer; 2015 Apr; 15():294. PubMed ID: 25880028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of body mass index in incidence and persistence of cervical human papillomavirus infection.
    Urbute A; Thomsen LT; Belmonte F; Kesmodel US; Frederiksen K; Kjaer SK
    Ann Epidemiol; 2020 Sep; 49():36-41. PubMed ID: 32711054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening for cervical and breast cancer: is obesity an unrecognized barrier to preventive care?
    Wee CC; McCarthy EP; Davis RB; Phillips RS
    Ann Intern Med; 2000 May; 132(9):697-704. PubMed ID: 10787362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adherence to Cervical Cancer Screening Programs in Migrant Populations: A Systematic Review and Meta-Analysis.
    Rosato I; Dalla Zuanna T; Tricarico V; Barbiellini Amidei C; Canova C
    Int J Environ Res Public Health; 2023 Jan; 20(3):. PubMed ID: 36767568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of obesity in differences in cervical cancer screening rates by migration history. The CONSTANCES survey.
    Crampe-Casnabet C; Franck JE; Ringa V; Coeuret-Pellicer M; Chauvin P; Menvielle G
    Cancer Epidemiol; 2019 Feb; 58():98-103. PubMed ID: 30530110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 'Weighing in' on screening mammography.
    Berz D; Sikov W; Colvin G; Weitzen S
    Breast Cancer Res Treat; 2009 Apr; 114(3):569-74. PubMed ID: 18491226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associated factors and global adherence of cervical cancer screening in 2019: a systematic analysis and modelling study.
    Zhang W; Gao K; Fowkes FJI; Adeloye D; Rudan I; Song P; Jin M; Chen K
    Global Health; 2022 Dec; 18(1):101. PubMed ID: 36494856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer screening among the overweight and obese in Canada.
    Mitchell RS; Padwal RS; Chuck AW; Klarenbach SW
    Am J Prev Med; 2008 Aug; 35(2):127-32. PubMed ID: 18617081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The association of obesity and cervical cancer screening: a systematic review and meta-analysis.
    Maruthur NM; Bolen SD; Brancati FL; Clark JM
    Obesity (Silver Spring); 2009 Feb; 17(2):375-81. PubMed ID: 18997682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cervical and breast cancer screening participation for women with chronic conditions in France: results from a national health survey.
    Constantinou P; Dray-Spira R; Menvielle G
    BMC Cancer; 2016 Mar; 16():255. PubMed ID: 27029643
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.